Biological DMARDs Flashcards
What are you worried about in giving any biological DMARD?
Infections! These drugs are immunosuppressors. Dont give them with active infections, and worry about getting infections or reactivating old ones (TB!)
What are the TNF-alpha blockers? What is their ADE?
- Adalimumab
- Etanercept
- Infliximab
- Golimumab
- Certolizumab pegol
ADE: Malignancies
Adalimumab MOA?
TNF-alpha mAb. Binds TNF-alpha and blocks interaction with p55 and p75
Adalimumab ADE?
Lupus like symptoms (arthralgia, myalgia, fatigue, skin rash), CHF
Etanercept structure?
TNF-alpha receptor/Ab fusion protein.. p75 bound to IgG1
Etanercept ADE
Lupus-like symptoms
Infliximab structure/MOA
Chimeric TNF-alpha mAb; binds soluble and transmembrane TNF-alpha
Infliximab ADE
CHF, Lupus like symptoms, LFTs
Golimumab structure/MOA
Human derived mAb to TNF-alpha, has variable and constant regions; binds soluble and transmembrane TNF-alpha
Golimumab ADE
Blood dyscrasia, Lupus like symptoms
Certolizumab pegol structure/MOA
Fab fragment of humanized TNF-alpha Ab; binds soluble and transmembrane TNF-alpha
Certolizumab pegol ADE
Blood dyscrasia, Lupus-like symptoms
Abatacept structure/MOA
CTLA4/IgG1 fusion protein; blocks CD28 from activating T cells
Abatacept ADE
Contains maltose which can mess w/ blood glucose test
Rituximab structure/MOA
Chimeric CD20/IgG1k mAb. Kills B cells. Sensitization to cytotoxic tx in B-cell lymphoma
Rituximab ADE
CHF, Blood dyscrasia, toxic epidermal necrolysis, Steven Johnson, Contraindicated in pregnancy
Anakinra structure/MOA
Recombinant IL-1 receptor antagonist –> decreases inflammatory response
Anakinra ADE
Blood dyscrasia
Tocilizumab structure/MOA
IL-6 receptor antagonist; binds to soluble and membrane bound IL-6 receptors –> decreases immune response regulator production
Tocilizumab ADE
Blood dyscrasia, LFTs (get serum lipids too)
Which biological DMARDs are administered SC?
Abatacept, Adalimumab, Anakinra, Certolizumab, Etancercpet, Bolimumab
Which bio DMARDs are IV?
Abatacept, Infliximab, Rituximab, Tocilizumab